| 1 |
Federation of Gynecology and Obstetrics
(1351 times)
|
Neoplasms
(660 times)
|
OS (177 times)
CI (80 times)
DFS (73 times)
|
1975 World Health Organization classification and nomenclature of ovarian cancer.
|
| 2 |
Federation Internationale de Gynecologie et d'Obstetrique
(71 times)
|
Neoplasms
(34 times)
|
OS (6 times)
MRI (4 times)
DFS (3 times)
|
1990 Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.
|
| 3 |
Federation of Obstetrics and Gynecology
(53 times)
|
Neoplasms
(19 times)
|
OS (5 times)
CT (4 times)
MRI (4 times)
|
1995 Associations between oncogenic human papillomaviruses and local invasive patterns in cervical cancer.
|
| 4 |
Federal International Gynecology Oncology
(3 times)
|
Gynecology
(2 times)
|
ERR (1 time)
MR (1 time)
|
1987 Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma.
|
| 5 |
federation international of Obstetrics and Gynecology
(2 times)
|
Medicine
(2 times)
|
AJOL (1 time)
FGM (1 time)
RICK (1 time)
|
2012 An overview of female genital mutilation in Nigeria.
|
| 6 |
factor in stage II and III
(1 time)
|
Neoplasms
(1 time)
|
LOH (1 time)
PCR (1 time)
|
2006 Loss of heterozygosity on chromosomes 2p, 3p, 18q21.3 and 11p15.5 as a poor prognostic factor in stage II and III (FIGO) cervical cancer treated by radiotherapy.
|
| 7 |
factors in stage III/IV
(1 time)
|
Gynecology
(1 time)
|
---
|
1987 [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
|
| 8 |
factors including the histological type, clinical stage
(1 time)
|
Gynecology
(1 time)
|
E-cadherin (1 time)
|
1992 [Immunohistochemical study on the expression of E-cadherin in normal tissues and squamous cell carcinomas of the uterine cervix].
|
| 9 |
factors that were significant--clinical tumor size, vulvar staging
(1 time)
|
Neoplasms
(1 time)
|
AJCC (1 time)
GOG (1 time)
|
1994 Malignant melanoma of the vulva treated by radical hemivulvectomy. A prospective study of the Gynecologic Oncology Group.
|
| 10 |
features, such as a pathological subtype of the tumor
(1 time)
|
Endocrinology
(1 time)
|
AMH (1 time)
|
2013 Serum anti-mullerian hormone levels in patients with epithelial ovarian cancer.
|
| 11 |
Federation of Gynecology
(1 time)
|
Gynecology
(1 time)
|
WHO (1 time)
|
1996 Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?
|
| 12 |
Federation of Gynecology and Obstetrics staging system
(1 time)
|
Biology
(1 time)
|
MS-MLPA (1 time)
|
2013 Hypermethylation of RAD51L3 and XRCC2 genes to predict late toxicity in chemoradiotherapy-treated cervical cancer patients.
|
| 13 |
female developed a stage IV
(1 time)
|
Reproductive Medicine
(1 time)
|
FSH (1 time)
GnRHa (1 time)
hCG (1 time)
|
1997 Sertoli-Leydig cell tumour in an infertile patient after stimulated ovulation.
|
| 14 |
field interaction and geometrical overlap
(1 time)
|
Chemistry
(1 time)
|
AI (1 time)
|
2003 Field interaction and geometrical overlap: a new simplex and experimental design based computational procedure for superposing small ligand molecules.
|
| 15 |
findings from clinical examination
(1 time)
|
Health Services Research
(1 time)
|
CI (1 time)
HR (1 time)
RCTs (1 time)
|
2015 Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
|
| 16 |
following conventional radiation treatment of Stage IIIB
(1 time)
|
Neoplasms
(1 time)
|
---
|
1980 Parametrial implants in the treatment of stage IIIB carcinoma of the cervix. II. Analysis of success and failure.
|
| 17 |
found between disease stages
(1 time)
|
Medicine
(1 time)
|
---
|
2006 Expression of Pin1 and Ki67 in cervical cancer and their significance.
|
| 18 |
found to be in an advanced stage, stage- III b
(1 time)
|
Microbiology
(1 time)
|
---
|
2007 Villoglandular papillary adenocarcinoma of cervix associated with cervical intraepithelial neoplasia: a case report and review of literature.
|
| 19 |
frequency of elevated cases according to the clinical stages
(1 time)
|
Neoplasms
(1 time)
|
---
|
1990 [Diagnosis: tumor marker].
|
| 20 |
functional status, tumor stage
(1 time)
|
Gynecology
(1 time)
|
---
|
2003 Centralizing surgery for gynecologic oncology--a strategy assuring better quality treatment?
|
A Search Service for Abbreviation / Long Form